A. Nguyen

发表

Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough

S. Birring, E. Bacci, C. La Rosa, 2022, Therapeutic advances in respiratory disease.

Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough

S. Birring, J. Smith, E. Bacci, 2022, Lung.

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

I. Pavord, S. Birring, J. Smith, 2022, The Lancet.

Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough

I. Pavord, S. Birring, A. Morice, 2021 .

S. Pignata, I. Ray-Coquard, N. Colombo, 2023, European Journal of Cancer.

The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough

P. Reyfman, L. McGarvey, Wen-Chi Wu, 2023, Lung.

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis

T. Wadden, S. Heymsfield, S. Heymsfield, 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Evidence for prospective associations among depression and obesity in population‐based studies

T. Wadden, S. Heymsfield, M. Butryn, 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis

T. Wadden, S. Heymsfield, S. Heymsfield, 2011, International Journal of Obesity.

Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: Is treatment with bisphosphonates an option?

P. Miller, A. Modi, R. Lubwama, 2014, Osteoporosis International.

Demographic, Clinical, and Patient-Reported Outcome Data From Two Global, Phase 3 Trials of Chronic Cough.

I. Pavord, S. Birring, J. Smith, 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Connecting the dots between breast cancer, obesity and alcohol consumption in middle-aged women: ecological and case control studies

Imogen Ramsey, E. Miller, Carlene J Wilson, 2018, BMC Public Health.

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.

Sandra M. Sanabria-Bohórquez, E. Ravussin, S. Heymsfield, 2008, Cell metabolism.

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis

T. Wadden, S. Heymsfield, M. Butryn, 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.